BioPlus Co Ltd
KOSDAQ:099430
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
KR |
|
C
|
Compagnie d'entreprises CFE SA
XBRU:CFEB
|
BE |
|
G
|
Group Up Industrial Co Ltd
TPEX:6664
|
TW |
|
G
|
Grindr Inc
NYSE:GRND
|
US |
|
S
|
Sinostar Pec Holdings Ltd
SGX:C9Q
|
CN |
|
BFF Bank SpA
OTC:BFFBF
|
IT |
|
A
|
ADS Maritime Holding PLC
OSE:ADS
|
NO |
BioPlus Co Ltd
BioPlus Co Ltd makes medical aesthetic products, especially hyaluronic acid-based dermal fillers used by doctors in cosmetic and reconstructive procedures. It also sells related beauty and skin-care products tied to the same anti-aging and tissue-care market. In simple terms, the company turns biomaterials into injectable products that help restore volume, smooth lines, and improve the look or feel of skin. Its main customers are clinics, hospitals, distributors, and other medical-aesthetics buyers, often through local and overseas sales channels. BioPlus makes money by selling finished products, and in some cases by supplying products through partners that market them under their own brands. That means its business depends on repeat orders from medical professionals and the regulatory approvals needed to sell these products in each market. What makes BioPlus different is that it sits in a niche part of healthcare where medicine and cosmetic treatment overlap. The company is not a drugmaker in the usual sense and not a general beauty company either; it sells physician-used products that are part of elective aesthetic care. That gives it a business model built around specialized formulations, medical distribution, and trusted use in clinics rather than mass retail.
BioPlus Co Ltd makes medical aesthetic products, especially hyaluronic acid-based dermal fillers used by doctors in cosmetic and reconstructive procedures. It also sells related beauty and skin-care products tied to the same anti-aging and tissue-care market. In simple terms, the company turns biomaterials into injectable products that help restore volume, smooth lines, and improve the look or feel of skin.
Its main customers are clinics, hospitals, distributors, and other medical-aesthetics buyers, often through local and overseas sales channels. BioPlus makes money by selling finished products, and in some cases by supplying products through partners that market them under their own brands. That means its business depends on repeat orders from medical professionals and the regulatory approvals needed to sell these products in each market.
What makes BioPlus different is that it sits in a niche part of healthcare where medicine and cosmetic treatment overlap. The company is not a drugmaker in the usual sense and not a general beauty company either; it sells physician-used products that are part of elective aesthetic care. That gives it a business model built around specialized formulations, medical distribution, and trusted use in clinics rather than mass retail.
